Latest Healthcare News

Page 49 of 150
XRF Scientific Limited has confirmed its fully franked ordinary dividend for the 2025 financial year and updated details of its Dividend Reinvestment Plan price, offering shareholders a clear view on income and reinvestment options.
Ada Torres
Ada Torres
26 Sept 2025
INOVIQ Limited has obtained exclusive worldwide rights to novel ovarian cancer biomarker IP from UniQuest, propelling its EXO-OC™ test closer to commercial launch. The test’s exceptional sensitivity and specificity position it as a potential breakthrough in early cancer detection.
Ada Torres
Ada Torres
26 Sept 2025
IMEXHS Limited has secured a significant one-year contract with Colombian cancer care provider Oncolife to deliver advanced radiology services, leveraging its integrated software and AI tools to enhance diagnostic precision.
Ada Torres
Ada Torres
26 Sept 2025
Memphasys Limited is intensifying its commercial push for Felix, an innovative automated sperm separation system for IVF, backed by a landmark Middle East partnership and a fresh capital raise to scale manufacturing and sales.
Ada Torres
Ada Torres
25 Sept 2025
Recce Pharmaceuticals has initiated patient dosing in its pivotal Phase 3 trial for diabetic foot infections in Indonesia, targeting a significant market with high diabetes prevalence. Interim results expected in early 2026 could accelerate regulatory approval and commercial launch.
Ada Torres
Ada Torres
25 Sept 2025
Invex Therapeutics has voluntarily suspended trading on the ASX pending a significant acquisition announcement and responses to a price query. The suspension is expected to last until the announcement or early next week.
Ada Torres
Ada Torres
25 Sept 2025
Sonic Healthcare announces a major leadership transition with Dr Colin Goldschmidt retiring after 32 years as CEO, succeeded by Dr Jim Newcombe. The company also appoints Evangelos Kotsopoulos as Chief Operating Officer to support its global growth ambitions.
Ada Torres
Ada Torres
25 Sept 2025
Cann Group Limited has reported its first-ever EBITDA-positive month in August 2025, driven by strong B2B flower sales and disciplined cost management. The company is advancing export negotiations in Europe and preparing to launch a new Botanitech product range.
Ada Torres
Ada Torres
25 Sept 2025
Vitura Health Limited has updated its dividend distribution details, confirming a fully franked ordinary dividend and issuing nearly 487,000 new shares under its Dividend Reinvestment Plan.
Ada Torres
Ada Torres
25 Sept 2025
Race Oncology has secured Investigational New Drug approval from South Korea’s regulatory authority, enabling Phase 1 clinical trials of RC220 in combination with doxorubicin for solid tumour patients across four Korean sites.
Ada Torres
Ada Torres
24 Sept 2025
EMVision Medical Devices has initiated a unique pre-hospital study in Melbourne to test its First Responder Brain Scanner within one of the world’s few Mobile Stroke Units, aiming to enhance stroke diagnosis and accelerate commercialisation.
Ada Torres
Ada Torres
24 Sept 2025
Micro-X Ltd has secured a $4.4 million Australian Government grant to develop and trial a portable Head CT scanner designed for standard ambulances, aiming to transform emergency stroke care with faster diagnosis and treatment.
Ada Torres
Ada Torres
23 Sept 2025